Associated Papers
Understanding the variant landscape, and genetic epidemiology of Multiple Endocrine Neoplasia in India.
Vatsyayan A et al.
Endocrine, 2024
Approach of Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome-Related Skin Tumors.
Băicoianu-Nițescu LC et al.
Diagnostics (basel, Switzerland), 2022
Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients.
Zhang J et al.
Frontiers in Oncology, 2021
35087742 (PubMed )
Supplement: Table_2.xlsx › Sheet1
Tumor suppressor loss in pituitary tumors.
Alexander JM
Brain Pathology (zurich, Switzerland), 2001
The MEN1 gene and associated diseases: an update.
Tsukada T et al.
Endocrine Pathology, 2001
Genetic disorders of calcium and phosphorus metabolism.
Root AW
Critical Reviews in Clinical Laboratory Sciences, 2000
Multiple endocrine neoplasia type 1.
Pannett AA et al.
Endocrine-related Cancer, 1999
Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
Giraud S et al.
American Journal of Human Genetics, 1998
11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
Weil RJ et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 1998
Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene.
Pack S et al.
The Journal of Investigative Dermatology, 1998
Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
Agarwal SK et al.
Human Mutation, 1998
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
Agarwal SK et al.
Human Molecular Genetics, 1997
Select a paper to view details